Navigation Links
Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants
Date:1/23/2010

LAKE FOREST, Ill., Jan. 22 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, and its philanthropic arm, the Hospira Foundation, have made initial donations of approximately $1.75 million in medical products and cash grants to support humanitarian relief efforts in Haiti. More than 750,000 units of Hospira products, valued at more than $1.5 million, are either in Haiti or en route to the country and include antibiotics, intravenous (I.V.) solutions, analgesics and anesthetics, all of which are in high demand and are integral to serving the needs of disaster victims.

"We are working closely with humanitarian aid agencies to help the people of Haiti obtain access to critical products needed in the provision of medical care," said Christopher B. Begley, chairman and chief executive officer. "The Hospira family expresses deep sympathy to all of the victims of this tragedy, and we will continue to work in the coming weeks and months to provide health and wellness to this devastated region."

In addition to donating products, Hospira has made a total of $200,000 in initial cash grants to the Red Cross and to the company's partners, which include AmeriCares, Direct Relief International, Catholic Medical Mission Board (CMMB) and Project Hope. Hospira also will match employee contributions dollar for dollar up to $50,000 through the Hospira Foundation.

Hospira will continue to monitor disaster relief efforts in Haiti, and will evaluate opportunities to provide additional assistance as further needs and information become available.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.

SOURCE Hospira, Inc.

RELATED LINKS
http://www.hospira.com

'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
2. Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
3. Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
4. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
5. Hospira Reports Third-Quarter 2009 Results
6. Hospira Names Daphne E. Jones Chief Information Officer
7. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
8. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
9. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
10. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
11. PROXY Governance Recommends Against Taros Board and Supports Sun
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Jan. 18, 2017 The Academy of ... Drug Administration (FDA) for its release today of ... health decision makers can proactively share clinical and ... well as emerging therapies awaiting FDA approval. ... recommendations that AMCP developed during two multi-stakeholder meetings ...
(Date:1/18/2017)... Jan. 18, 2017  EnteroMedics Inc. (NASDAQ: ... using neuroblocking technology to treat obesity, metabolic diseases ... of an underwritten public offering of units for ... underwriting discounts and commissions and offering expenses payable ... of Class A Units, priced at a public ...
(Date:1/18/2017)... India , January 18, 2017 ... Imaging Technologies Market by Type: Global Opportunity Analysis and Industry ... size was valued at $2,544 million in 2015 and is ... CAGR of 8.4% from 2016 to 2022. North ... accounted for over three-fourths market share in 2015. Ionizing breast ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... ... Connecticut Dermatology Group (CDG) is proud and excited to welcome back to ... Kim brings an extensive background in cutting-edge dermatology care and research to Connecticut’s largest ... Dr. Kim to the CDG team” said President and Managing Partner Dr. Steven A. ...
(Date:1/19/2017)... ... January 19, 2017 , ... Infinity® Massage Chairs announced today ... implement new sales and marketing strategies. Grover comes with a total of 15 years ... a half years as Executive Vice President of Direct Sales at Traeger® Wood Pellet ...
(Date:1/18/2017)... ... January 18, 2017 , ... A recent video posting ... global discussion about the benefits of fidgeting to relieve stress and anxiety. No ... Their Think Ink Pen had just completed a successful Kickstarter campaign raising $67,000 ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... of Bioengineering are collaborating on a research project focused on multiple sclerosis (MS). ... seeks to use nanotechnology to control the disease without compromising normal immune function ...
(Date:1/18/2017)... ... January 18, 2017 , ... A Palm Beach doctor plans to run ... international charity that provides free surgery to poor children suffering from cleft lip and ... I have run to support the efforts of the American Heart Association and the ...
Breaking Medicine News(10 mins):